tiprankstipranks
Cizzle Biotechnology’s Progress on Lung Cancer Test
Company Announcements

Cizzle Biotechnology’s Progress on Lung Cancer Test

Cizzle Biotechnology Holdings PLC (GB:CIZ) has released an update.

Pick the best stocks and maximize your portfolio:

Cizzle Biotechnology Holdings PLC, a UK diagnostics developer, has released its Annual Report and Financial Statements for the fiscal year ending December 31, 2023. The report is accessible online and details the company’s progress on developing an early detection blood test for lung cancer, leveraging a biomarker associated with early-stage disease. Investors and the public can stay informed through the company’s website and social media channels.

For further insights into GB:CIZ stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskCizzle Biotechnology Expands Lung Cancer Diagnostic Reach to the Caribbean
TipRanks UK Auto-Generated NewsdeskCizzle Biotechnology Enters Strategic North American Partnership
TipRanks UK Auto-Generated NewsdeskCizzle Biotech Nears Major US Licensing Deal
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App